The human ras gene plays a fundamental role in the transduction of extracellular signals to the nucleus, thereby regulating cell growth and differentiation. Point mutations in the ras gene convert it into a transforming oncogene that has been found in many solid and hematologic malignancies. We describe a rapid and sensitive assaybasedon a radiolabeled polymerase chainreaction followed by restriction enzyme digestion that we have adaptedfordifferentiating between the wild-type and mutant ras genes. This assay shouldprove useful in the analysisof ras gene point mutations in clinical tumor specimensin whichras oncogene activation is an early event in carcinogenesis.
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The human ras gene family includes the Ha-, Ki-, and N-ras genes, all of which encode homologous GTP binding proteins that play a role in signal transduction. 
Point mutations in the ras

By using radioactive dNTPs and mismatched
Ki-ras primers, we have adapted a PCR-based assay to distinguish between wild-type and mutant DNA templates after restriction enzyme digestion.
We have compared this assay with other techniques and show that it is a rapid and sensitive method for detecting ras gene point mutations in a heterogeneous cell population. at codon 12 was performed according to the previously described method (8, 10). Briefly, 50 iL of each PCR sample was run on a 2% agarose gel, and, after incubation in 16 mmol/L HC1 for 30 min, the gel was transferred to Immobion N (Millipore, Bedford, MA) in 0.4 mol/L NaOH. The oligonucleotide used for hybridization was 5'-GGAGCTGTTGGCGTAGGCAA.
Materials and Methods
3' for the valine codon-12-mut.ant
Ki-ras. The oligonucleotide was labeled with 32P and T4 polynucleotide kinase to a specific activity of _108 dpm/ig.
Hybridization was performed at 52#{176}C for 6 h. After hybridization, the membranes were rinsed in 3x SSC (450 mmol/L sodium chloride, 18 mmoWL sodium citrate, and 1 mmol/L Tris-HC1, pH 7.2), 1 g/L sodium dodecyl sulfate at room temperature for 5 mm, and then washed at 56#{176}C in 3x SSC, 1 gIL sodium dodecyl sulfate for 30 miii. The filters were then exposed to film at -70#{176}C for 2-6 h.
Radioactive PCR. Radioactive PCR was carried out in a 100-.tL volume with the following modifications:
The concentration of cold dCTP was reduced to 0.25 mmolJL, and 0.5 .tL of [a-32P]dCTP (3000 Cimol/L) (New England Nuclear) was added to the reactions. After amplification, 5 iL of each PCR sample was digested with 2 tL (16 U) of BstNI in a 20-pL volume at 60#{176}C for 14-16 h. The digests were run on an 8% native acrylainide gel for 4-5 h. The gel was wrapped in plastic wrap and exposed to film at room temperature for 2-6 h. Single-strand conformation polymorphism (SSCP) analysis. Ki-ras codon-12 mutation was detected with a modified version of the SSCP method (10, 11). Following radioactive PCR as described above, 2 j.&Lof the PCR product was mixed with 8 L of loading buffer (950 mLJL formamide, 20 mmol/L EDTA, 0.5 g/L xylene cyanol, 0.5 g/L bromphenol blue) and incubated at 95#{176}C for 5 miii. We loaded 2 L of each sample on a 6% acrylamide gel containing 100 mLfL glycerol. The gel was run at 40W constant power for 3-4 h at 4#{176}C with lx TBE (89 mmol/L Tris-borate, 2 mmol/L EDTA, pH 8.3) as running buffer. The gel was dried and exposed to film at -70#{176}C for 14 h.
Results
Detection of Ki-ras codon-12 and -13 mutations in colon carcinoma cell lines. Genomic DNA prepared from 14 colon carcinoma cell lines was amplified with the primers KRAS5' and KRAS3', generating a DNA fragment of 157 nucleotides.
The KRAS5' primer is 30 nucleotides long and incorporates a cytosine residue at the first position of codon 11 and terminates adjacent to codon 12 (Fig. 1) . A single nucleotide substitution is also incorporated into the KRAS3' primer as a positive control for BstNI cleavage.
The Ki-ras codon-12 mutation was detected with BstNI digestion and liquid hybridization in the SW480, SK-CO1, and LS-174T cell lines (Fig.  2) . Upon incubation with BstNI, fragments encoding wild-type codon-12 sequences were cleaved twice, resulting in the largest band of 114 nucleotides.
Fragments containing mutations at either the first or second positions of codon 12 were cleaved only once, resulting in a longer band of 143 nucleotides (Fig. 1) . In the SW480 cell line, only the mutant band was observed and this is consistent with the previously reported results that the SW480 cell lines is homozygous for the codon-12 valine allele (12). In the SK-COl and LS-174T cell lines, both the mutant and the wild-type bands were observed, indicating the presence of both mutant and wild-type alleles (Fig. 2) .
Mutant
The Ki-ras codon-13 aspartic acid mutation was screened with the same PCR products from 11 colon carcinoma cell lines. The PCR fragment was digested with the restriction enzyme HphI. Transition to an adenosine residue at the second position of codon 13 results in the substitution of glycine to aspartic acid and creates an HphI site. Wild-type DNA fragments remained undigested, while codon-13 aspartic acid mutant.s were cleaved to a 114-nucleotide band (Fig. 1) . The mutant band was observed in the HCT116, T84, and LoVo cell lines (Fig. 3) . These cell lines also have the wild-type band; no cell line tested was homozygous for the aspartic acid allele of the Ki-ras codon 13.
Restriction enzyme analysis. Genomic DNA from the SW480 colon carcinoma cell line, which is homozygous for the Ki-ras codon-l2 valine mutation, was serially diluted with genomic DNA prepared from the HT29 . 157b colon carcinoma cell line, which has a wild-type Ki-ras gene. These mixtures were amplified by PCR. PCRamplified samples digestedwith BstNI were run on an 8% native acrylamide gel. As expected, only the 143-nucleotide mutant band and the 114-nucleotide wildtype band were visible in the 1:0 and the 0:1 dilutions, respectively.
The 143-nucleotide mutant band was still detectable in the 1:32 dilution (data not shown). Previously, the sensitivity for K-ras codon-12 mutation with the same method was reported as 1:16 dilution (5).
While this method is simple and nonradioactive, it is not sensitive enough to detect a ras mutation in clinical samples with a vast excess of normal cells.
Liquid hybridization assay. We compared four different methods for sensitivity and specificity of detection of the Ki-ras codon-12 mutation.
All methods were performed at least five times and conditions optimized as reported in previous studies (5) (6) (7) (8) . PCR fragments were digested with BstNI and the digest was mixed with the K-ras first exon probe (KRASY) (Fig. 1) for liquid hybridization (7) . Hybridization of the radiolabeled probe to the target-amplified DNA results in the formation of hemiduplexes, which can be separated from the free probe by electrophoresis in the native acrylamide gel. The 143-nucleotide mutant band was stifi detectable in the i:iO-iO dilution (Fig. 4) . A potential problem with this assay is the generation of false-positive results due to incomplete digestion of the sample with BstNI. To try to eliminate this problem, we used only 5 pL of the 100-L PCR product and digested it for 14-16 h with
-. Ratios of SW480 to H129 DNA are given above the sample lanes. Fig. 7 . Detectionof Ki-ras codon-12 mutationwith SSCPanalysis.
SW480 DNA and HT29 DNA were mixed in 10-fold serial dilutions. Mixtures were labeled by incorporating 32P during PCR with KRAS5' and KRAS3' primers. The PCR product was subjected to SSCP analysis.
708 CLINICALCHEMISTRY, Vol. 40, No. 5, 1994 BstNI, as our initial results showed that even 8 h of digestion of the 5-L PCR product with BstNl generated incompletely digested bands. Although 14-16 h of digestion improved sensitivity, there were persistent problems with background bands (Fig. 4) .
PCR and Southern hybridization.
In this method, extremely stringent hybridization and washing conditions are required to ensure that the mutant oligonucleotide (differing at a single base from the wild-type sequence) hybridizes only to mutant molecules, resulting in the appropriate signal-to-noise ratio. Even slightly nonideal conditions led to false-positive results, and too stringent conditions decreased the sensitivity. Although this method has been successfully used to identify mutant ras molecules in stool samples from patients with large colomc tumors, its sensitivity remains undocumented (8). We used the sequence-specific oligonucleotide with a high specific activity (_108 dpin/g) and chose the stringent hybridization and washing conditions described above. In our optimized conditionsfor this assay, the mutant signal was still visible in the 102_103 dilution range (Fig. 5) 
Stringent hybridization
and washing conditions are required for the appropriate signal-to-noise ratio. Radiolabeled PCR followed by restriction enzyme digestion proved to be faster and more sensitive than the PCRI Southern assay.
A liquid hybridization approach involving PCR amplification with mismatched oligonucleotides, diagnostic restriction enzyme digestion, and detection with a radiolabeledprobe was extensivelyexamined.
The radiolabeled PCR assay we describe is an adaptation of this technique.
Although the liquid hybridization assay is as quick and sensitive as the radiolabeled PCR method, its applicability is limited by higher background noise, making interpretation difficult. Furthermore, hybridization and washing steps are obviated in the radiolabeled PCR method. An SSCP-based approach has low sensitivitywhen compared with all other techniques tested, and thus its application to clinical material is limited.
We conclude that the radiolabeled PCR method followed by diagnostic restriction enzyme digestion is a rapid and sensitive means of detecting ras gene point mutations (Table 1) 
